B. Riley downgraded Joint Corp. (JYNT) to Neutral from Buy with a price target of $9, down from $18. The company’s Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint’s fiscal 2025 as “transitional,” as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JYNT: